July 30: Structuring Biotech & Pharma Startup Portfolios for Global Impact, Value, and Partnering

With continued significant investment by venture, PE, and pharma communities in biotech clusters around the world, ensuring that your portfolio can provide maximum value on a global scale for ultimate partnering or acquisition is a crucial element of any startup’s strategic plan. Important considerations include:

• Balancing early filing/first to file realities with meeting enablement and support requirements in the US and around the world
• You can’t do it all alone: best practices for working with CROs, consultants, and universities
• Even though you have a million other things to focus on, don’t forget the details: inventorship, ownership, and chain of title.

On Tuesday, July 30, please join Fish attorneys Teresa Lavoie and Angela Follett as they discuss global filing and portfolio strategies for startups in the biotech and pharma sectors.
Title:
Structuring Biotech & Pharma Startup Portfolios for Global Impact, Value, and Partnering
Webinar Date+Time:
Thursday, July 30, 2020
1:30 – 2:30 pm EDT
Register Now!
Speakers:
Teresa A. Lavoie, Ph.D.
Angela D. Follett, Ph.D.
By:
Fish & Richardson, P.C.
Credit:
Fish & Richardson will apply for 1.0 hour of CLE credit.
Register Now!